The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Perphenazine-Global Market Insights and Sales Trends 2025
Synopsis
Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.
The global Perphenazine market size is expected to reach US$ 123.2 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Perphenazine in various end use industries. The expanding demands from the Psychosis and Antiemetic, are propelling Perphenazine market. Oral Forms, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable Solution segment is estimated at % CAGR for the next seven-year period.
Global Perphenazine key players include Teva, Sandoz, Endo, Mylan, ZHPHARMA etc. Global top five manufacturers hold a share over 80%.
North America is the largest market, with a share over 50%, followed by Asia-Pacific and Europe, both have a share over 20% percent.
In terms of product, Oral Forms is the largest segment, with a share over 90%. And in terms of application, the largest application is Psychosis followed by Antiemetic.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Perphenazine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Perphenazine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Perphenazine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Perphenazine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Perphenazine covered in this report include Teva, Sandoz, Endo, Mylan, ZHPHARMA and Shandong Boshan Pharma, etc.
The global Perphenazine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Sandoz
Endo
Mylan
ZHPHARMA
Shandong Boshan Pharma
Global Perphenazine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Perphenazine market, Segment by Type:
Oral Forms
Injectable Solution
Global Perphenazine market, by Application
Psychosis
Antiemetic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Perphenazine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Perphenazine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.
The global Perphenazine market size is expected to reach US$ 123.2 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Perphenazine in various end use industries. The expanding demands from the Psychosis and Antiemetic, are propelling Perphenazine market. Oral Forms, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable Solution segment is estimated at % CAGR for the next seven-year period.
Global Perphenazine key players include Teva, Sandoz, Endo, Mylan, ZHPHARMA etc. Global top five manufacturers hold a share over 80%.
North America is the largest market, with a share over 50%, followed by Asia-Pacific and Europe, both have a share over 20% percent.
In terms of product, Oral Forms is the largest segment, with a share over 90%. And in terms of application, the largest application is Psychosis followed by Antiemetic.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Perphenazine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Perphenazine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Perphenazine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Perphenazine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Perphenazine covered in this report include Teva, Sandoz, Endo, Mylan, ZHPHARMA and Shandong Boshan Pharma, etc.
The global Perphenazine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Sandoz
Endo
Mylan
ZHPHARMA
Shandong Boshan Pharma
Global Perphenazine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Perphenazine market, Segment by Type:
Oral Forms
Injectable Solution
Global Perphenazine market, by Application
Psychosis
Antiemetic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Perphenazine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Perphenazine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Perphenazine Market Overview
1.1 Perphenazine Product Overview
1.2 Perphenazine Market Segment by Type
1.2.1 Oral Forms
1.2.2 Injectable Solution
1.3 Global Perphenazine Market Size by Type
1.3.1 Global Perphenazine Market Size Overview by Type (2018-2029)
1.3.2 Global Perphenazine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Perphenazine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Perphenazine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Perphenazine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Perphenazine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Perphenazine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Perphenazine Sales Breakdown by Type (2018-2023)
2 Global Perphenazine Market Competition by Company
2.1 Global Top Players by Perphenazine Sales (2018-2023)
2.2 Global Top Players by Perphenazine Revenue (2018-2023)
2.3 Global Top Players by Perphenazine Price (2018-2023)
2.4 Global Top Manufacturers Perphenazine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Perphenazine Market Competitive Situation and Trends
2.5.1 Perphenazine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Perphenazine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Perphenazine as of 2022)
2.7 Date of Key Manufacturers Enter into Perphenazine Market
2.8 Key Manufacturers Perphenazine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Perphenazine Status and Outlook by Region
3.1 Global Perphenazine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Perphenazine Historic Market Size by Region
3.2.1 Global Perphenazine Sales in Volume by Region (2018-2023)
3.2.2 Global Perphenazine Sales in Value by Region (2018-2023)
3.2.3 Global Perphenazine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Perphenazine Forecasted Market Size by Region
3.3.1 Global Perphenazine Sales in Volume by Region (2024-2029)
3.3.2 Global Perphenazine Sales in Value by Region (2024-2029)
3.3.3 Global Perphenazine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Perphenazine by Application
4.1 Perphenazine Market Segment by Application
4.1.1 Psychosis
4.1.2 Antiemetic
4.2 Global Perphenazine Market Size by Application
4.2.1 Global Perphenazine Market Size Overview by Application (2018-2029)
4.2.2 Global Perphenazine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Perphenazine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Perphenazine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Perphenazine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Perphenazine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Perphenazine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Perphenazine Sales Breakdown by Application (2018-2023)
5 North America Perphenazine by Country
5.1 North America Perphenazine Historic Market Size by Country
5.1.1 North America Perphenazine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Perphenazine Sales in Volume by Country (2018-2023)
5.1.3 North America Perphenazine Sales in Value by Country (2018-2023)
5.2 North America Perphenazine Forecasted Market Size by Country
5.2.1 North America Perphenazine Sales in Volume by Country (2024-2029)
5.2.2 North America Perphenazine Sales in Value by Country (2024-2029)
6 Europe Perphenazine by Country
6.1 Europe Perphenazine Historic Market Size by Country
6.1.1 Europe Perphenazine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Perphenazine Sales in Volume by Country (2018-2023)
6.1.3 Europe Perphenazine Sales in Value by Country (2018-2023)
6.2 Europe Perphenazine Forecasted Market Size by Country
6.2.1 Europe Perphenazine Sales in Volume by Country (2024-2029)
6.2.2 Europe Perphenazine Sales in Value by Country (2024-2029)
7 Asia-Pacific Perphenazine by Region
7.1 Asia-Pacific Perphenazine Historic Market Size by Region
7.1.1 Asia-Pacific Perphenazine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Perphenazine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Perphenazine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Perphenazine Forecasted Market Size by Region
7.2.1 Asia-Pacific Perphenazine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Perphenazine Sales in Value by Region (2024-2029)
8 Latin America Perphenazine by Country
8.1 Latin America Perphenazine Historic Market Size by Country
8.1.1 Latin America Perphenazine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Perphenazine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Perphenazine Sales in Value by Country (2018-2023)
8.2 Latin America Perphenazine Forecasted Market Size by Country
8.2.1 Latin America Perphenazine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Perphenazine Sales in Value by Country (2024-2029)
9 Middle East and Africa Perphenazine by Country
9.1 Middle East and Africa Perphenazine Historic Market Size by Country
9.1.1 Middle East and Africa Perphenazine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Perphenazine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Perphenazine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Perphenazine Forecasted Market Size by Country
9.2.1 Middle East and Africa Perphenazine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Perphenazine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Teva
10.1.1 Teva Company Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Perphenazine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Teva Perphenazine Products Offered
10.1.5 Teva Recent Development
10.2 Sandoz
10.2.1 Sandoz Company Information
10.2.2 Sandoz Introduction and Business Overview
10.2.3 Sandoz Perphenazine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sandoz Perphenazine Products Offered
10.2.5 Sandoz Recent Development
10.3 Endo
10.3.1 Endo Company Information
10.3.2 Endo Introduction and Business Overview
10.3.3 Endo Perphenazine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Endo Perphenazine Products Offered
10.3.5 Endo Recent Development
10.4 Mylan
10.4.1 Mylan Company Information
10.4.2 Mylan Introduction and Business Overview
10.4.3 Mylan Perphenazine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mylan Perphenazine Products Offered
10.4.5 Mylan Recent Development
10.5 ZHPHARMA
10.5.1 ZHPHARMA Company Information
10.5.2 ZHPHARMA Introduction and Business Overview
10.5.3 ZHPHARMA Perphenazine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 ZHPHARMA Perphenazine Products Offered
10.5.5 ZHPHARMA Recent Development
10.6 Shandong Boshan Pharma
10.6.1 Shandong Boshan Pharma Company Information
10.6.2 Shandong Boshan Pharma Introduction and Business Overview
10.6.3 Shandong Boshan Pharma Perphenazine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Shandong Boshan Pharma Perphenazine Products Offered
10.6.5 Shandong Boshan Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Perphenazine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Perphenazine Industrial Chain Analysis
11.4 Perphenazine Market Dynamics
11.4.1 Perphenazine Industry Trends
11.4.2 Perphenazine Market Drivers
11.4.3 Perphenazine Market Challenges
11.4.4 Perphenazine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Perphenazine Distributors
12.3 Perphenazine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
